Surgical Innovations returned to double digit growth in H2, bringing FY19 results in line with expectations. After a difficult H1, particularly around well publicised issues with the NHS, this is a creditable performance and should reassure that the market backdrop is stabilising and Surgical Innovations is back on the front foot. We continue to see material value creation opportunities ahead and look forward to a positive 2020.
13 Jan 2020
In line FY trading update reassures
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
In line FY trading update reassures
Surgical Innovations Group plc (SUN:LON) | 0.5 0 0.0% | Mkt Cap: 4.66m
- Published:
13 Jan 2020 -
Author:
Chris Glasper -
Pages:
3
Surgical Innovations returned to double digit growth in H2, bringing FY19 results in line with expectations. After a difficult H1, particularly around well publicised issues with the NHS, this is a creditable performance and should reassure that the market backdrop is stabilising and Surgical Innovations is back on the front foot. We continue to see material value creation opportunities ahead and look forward to a positive 2020.